Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 2
2020 3
2021 2
2023 5
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Results by year

Filters applied: . Clear all
Page 1
Identification of a miRNA multi-targeting therapeutic strategy in glioblastoma.
Bassot A, Dragic H, Haddad SA, Moindrot L, Odouard S, Corlazzoli F, Marinari E, Bomane A, Brassens A, Marteyn A, Hibaoui Y, Petty TJ, Chalabi-Dchar M, Larrouquere L, Zdobnov EM, Legrand N, Tamburini J, Lincet H, Castets M, Yebra M, Migliorini D, Dutoit V, Walker PR, Preynat-Seauve O, Dietrich PY, Cosset É. Bassot A, et al. Among authors: larrouquere l. Cell Death Dis. 2023 Sep 25;14(9):630. doi: 10.1038/s41419-023-06117-z. Cell Death Dis. 2023. PMID: 37749143 Free PMC article.
Pharmacotherapy for leptomeningeal disease in breast cancer.
Bartsch R, Jerzak KJ, Larrouquere L, Müller V, Le Rhun E. Bartsch R, et al. Among authors: larrouquere l. Cancer Treat Rev. 2024 Jan;122:102653. doi: 10.1016/j.ctrv.2023.102653. Epub 2023 Nov 7. Cancer Treat Rev. 2024. PMID: 38118373 Free article. Review.
A Glial Signature and Wnt7 Signaling Regulate Glioma-Vascular Interactions and Tumor Microenvironment.
Griveau A, Seano G, Shelton SJ, Kupp R, Jahangiri A, Obernier K, Krishnan S, Lindberg OR, Yuen TJ, Tien AC, Sabo JK, Wang N, Chen I, Kloepper J, Larrouquere L, Ghosh M, Tirosh I, Huillard E, Alvarez-Buylla A, Oldham MC, Persson AI, Weiss WA, Batchelor TT, Stemmer-Rachamimov A, Suvà ML, Phillips JJ, Aghi MK, Mehta S, Jain RK, Rowitch DH. Griveau A, et al. Among authors: larrouquere l. Cancer Cell. 2018 May 14;33(5):874-889.e7. doi: 10.1016/j.ccell.2018.03.020. Epub 2018 Apr 19. Cancer Cell. 2018. PMID: 29681511 Free PMC article.
Externally Controlled Trials: Are We There Yet?
Larrouquere L, Giai J, Cracowski JL, Bailly S, Roustit M. Larrouquere L, et al. Clin Pharmacol Ther. 2020 Nov;108(5):918-919. doi: 10.1002/cpt.1881. Epub 2020 Jun 15. Clin Pharmacol Ther. 2020. PMID: 32542679 No abstract available.
Tucatinib Combination Treatment After Trastuzumab-Deruxtecan in Patients With ERBB2-Positive Metastatic Breast Cancer.
Frenel JS, Zeghondy J, Guérin-Charbonnel C, Mailliez A, Volant E, Poumeaud F, Patsouris A, Arnedos M, Bailleux C, Cabal J, Galland L, de Nonneville A, Guiu S, Dalenc F, Pistilli B, Bachelot T, Pierga JY, Le Du F, Bocquet F, Larrouquere L, Loirat D. Frenel JS, et al. Among authors: larrouquere l. JAMA Netw Open. 2024 Apr 1;7(4):e244435. doi: 10.1001/jamanetworkopen.2024.4435. JAMA Netw Open. 2024. PMID: 38568692 Free PMC article.
Long-term response to sequential anti-HER2 therapies including trastuzumab-deruxtecan in a patient with HER2-positive metastatic breast cancer with leptomeningeal metastases: a case report and review of the literature.
de Bernardi A, Bachelot T, Larrouquère L. de Bernardi A, et al. Among authors: larrouquere l. Front Oncol. 2024 Jan 10;13:1210873. doi: 10.3389/fonc.2023.1210873. eCollection 2023. Front Oncol. 2024. PMID: 38269026 Free PMC article. Review.
13 results